thiazoles has been researched along with simvastatin in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, MK; Lin, JC | 1 |
| Caldwell, SH; Hespenheide, EE; von Borstel, RW | 1 |
| Amin, RD; Dilzer, S; Gagliano, K; Kuznetsova, O; Lasseter, KC; Liu, L; Musser, B; Prueksaritanont, T; Roadcap, BA; Rogers, JD; Vega, JM; Zhao, J | 1 |
| Demant, T | 1 |
| Abourjaily, HM; Alsheikh-Ali, AA; Karas, RH | 1 |
| Hoogwerf, BJ; Nambi, V; Sprecher, DL | 1 |
| Lawrence, I | 1 |
| Giehl, K; Goppelt-Struebe, M; Graness, A; Iwanciw, D; Ott, C | 1 |
| Berger, JP; Biswas, C; Chao, YS; Doebber, TW; Ippolito, MC; Kelly, LJ; Li, Y; Meurer, R; Moller, DE; Wang, PR; Wright, SD; Wu, MS; Zhou, G | 1 |
| Crisby, M; Lindberg, C; Schultzberg, M; Winblad, B | 1 |
| Kalgutkar, AS; Obach, RS; Soglia, JR; Zhao, SX | 1 |
| Fonseca, AC; Oliveira, CR; Pereira, CM; Proença, T; Resende, R | 1 |
| Dean, IN; Rawal, SY; Stein, SH; Tipton, DA | 1 |
| Alexander, R; Bettica, P; Gomeni, R; Nucci, G; Pyke, C; Ratti, E; Squassante, L; Zamuner, S | 1 |
| Choi, GW; Kim, EC; Lee, SI; Lee, SY; Min, KS; Park, JH; Park, SH | 1 |
| Gupta, A; Kalonia, H; Kumar, A; Mishra, J; Sharma, N | 1 |
| Saewong, S; Thammasitboon, K; Wattanaroonwong, N | 1 |
| Hasunuma, T; Jang, IJ; Kaneko, M; Kaniwa, N; Kawai, S; Saito, Y; Takeuchi, M; Tohkin, M; Uyama, Y; Watanabe, H; Yamazoe, Y; Yimin, C | 1 |
| Coban, N; Erginel-Unaltuna, N; Gulec, C; Ozsait-Selcuk, B | 1 |
1 review(s) available for thiazoles and simvastatin
| Article | Year |
|---|---|
A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia.
Topics: Angiotensin-Converting Enzyme Inhibitors; Female; Humans; Hyperinsulinism; Hypertension; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Male; Metabolic Syndrome; Metformin; Motor Activity; Obesity; Simvastatin; Thiazoles; Thiazolidinediones; Weight Loss | 2002 |
3 trial(s) available for thiazoles and simvastatin
| Article | Year |
|---|---|
Interactions between simvastatin and troglitazone or pioglitazone in healthy subjects.
Topics: Administration, Oral; Adult; Analysis of Variance; Area Under Curve; Chromans; Confidence Intervals; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Female; Headache; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Simvastatin; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist.
Topics: Adolescent; Adult; Arousal; Benzofurans; Cognition; Dose-Response Relationship, Drug; Drug Interactions; Electroencephalography; Half-Life; Humans; Hypnotics and Sedatives; Male; Middle Aged; Orexin Receptors; Polysomnography; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Simvastatin; Single-Blind Method; Sleep; Sleep Stages; Thiazoles; Wakefulness | 2012 |
Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians.
Topics: Adult; Asian People; Cytochrome P-450 CYP2C9; Fluoroquinolones; Glucuronosyltransferase; Humans; Liver-Specific Organic Anion Transporter 1; Male; Meloxicam; Moxifloxacin; Polymorphism, Genetic; Simvastatin; Thiazines; Thiazoles; White People; Young Adult | 2016 |
15 other study(ies) available for thiazoles and simvastatin
| Article | Year |
|---|---|
A drug interaction between troglitazone and simvastatin.
Topics: Cholesterol, LDL; Chromans; Diabetes Mellitus, Type 2; Drug Interactions; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Retrospective Studies; Simvastatin; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin.
Topics: Aged; Anticholesteremic Agents; Antioxidants; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypoglycemic Agents; Liver Cirrhosis; Myositis; Simvastatin; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
[Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects].
Topics: Anticholesteremic Agents; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Chromans; Clinical Trials as Topic; Coronary Disease; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Hyperlipoproteinemias; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Risk Factors; Simvastatin; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose).
Topics: Acarbose; Adverse Drug Reaction Reporting Systems; Anticholesteremic Agents; Atorvastatin; Chromans; Drug Interactions; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Pyrroles; Simvastatin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones; Troglitazone | 2002 |
Continuing education.
Topics: Adult; Aged; Anticholesteremic Agents; Coronary Disease; Diabetic Angiopathies; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Simvastatin; Thiazoles; Thiazolidinediones | 2003 |
Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton.
Topics: Actins; Amides; Bacterial Proteins; Bacterial Toxins; Botulinum Toxins; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Transformed; Colchicine; Connective Tissue Growth Factor; Cytochalasin D; Cytoskeleton; Fibroblasts; Gene Expression Regulation; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Kidney; Nocodazole; Paclitaxel; Pyridines; rhoA GTP-Binding Protein; Signal Transduction; Simvastatin; Stress, Mechanical; Thiazoles; Thiazolidines | 2003 |
MK-0767, a novel dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activities.
Topics: Animals; Benzamides; Blood Glucose; Chlorocebus aethiops; Cholesterol; COS Cells; Cricetinae; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Male; Mesocricetus; Mice; Mice, Obese; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Simvastatin; Thiazoles; Thiazolidinediones; Trans-Activators; Transcription Factors; Transcriptional Activation; Triglycerides | 2004 |
Effects of statins on microglia.
Topics: Amyloid beta-Peptides; Animals; Atorvastatin; Cell Death; Cell Line; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Drug Interactions; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; L-Lactate Dehydrogenase; Lipopolysaccharides; Microglia; Peptide Fragments; Pyrroles; Rats; Simvastatin; Statistics, Nonparametric; Tetrazolium Salts; Thiazoles | 2005 |
Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.
Topics: Acetaminophen; Binding Sites; Buspirone; Carbamazepine; Diclofenac; Diphenhydramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatocytes; Humans; Indomethacin; Meloxicam; Microsomes, Liver; Molecular Structure; Paroxetine; Piperazines; Propranolol; Raloxifene Hydrochloride; Simvastatin; Structure-Activity Relationship; Thiazines; Thiazoles; Ticrynafen; Toxicity Tests; Triazoles | 2008 |
Neuroprotective effects of statins in an in vitro model of Alzheimer's disease.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Calcium; Caspase 3; Cell Survival; Cells, Cultured; Cerebral Cortex; Cholesterol; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Extracellular Signal-Regulated MAP Kinases; In Situ Nick-End Labeling; Lovastatin; Neurons; Neuroprotective Agents; Oncogene Protein v-akt; Peptide Fragments; Rats; Rats, Wistar; Reactive Oxygen Species; Simvastatin; Tetrazolium Salts; Thiazoles; Time Factors | 2009 |
Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts.
Topics: Atorvastatin; Cell Culture Techniques; Cell Survival; Cells, Cultured; Coloring Agents; Culture Media, Serum-Free; Fibroblasts; Gingiva; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1beta; Osteoprotegerin; Pyrroles; RANK Ligand; Simvastatin; Temperature; Tetrazolium Salts; Thiazoles; Time Factors | 2011 |
Effects of simvastain and enamel matrix derivative on Portland cement with bismuth oxide-induced growth and odontoblastic differentiation in human dental pulp cells.
Topics: Alkaline Phosphatase; Aluminum Compounds; Anthraquinones; Biocompatible Materials; Bismuth; Calcification, Physiologic; Calcium Compounds; Cell Culture Techniques; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Coloring Agents; Core Binding Factor Alpha 1 Subunit; Dental Cements; Dental Enamel Proteins; Dental Pulp; Drug Combinations; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Materials Testing; Odontoblasts; Odontogenesis; Osteocalcin; Osteopontin; Oxides; Pulp Capping and Pulpectomy Agents; Reverse Transcriptase Polymerase Chain Reaction; Silicates; Simvastatin; Sp7 Transcription Factor; Tetrazolium Salts; Thiazoles; Transcription Factors | 2012 |
Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms.
Topics: Amphetamine; Analysis of Variance; Animals; Atorvastatin; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Glutathione; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Malondialdehyde; Mitochondria; Motor Activity; NADH Dehydrogenase; Nitrites; Oxidopamine; Parkinsonian Disorders; Pyrroles; Rats; Rats, Wistar; Simvastatin; Tetrazolium Salts; Thiazoles; Tumor Necrosis Factor-alpha | 2012 |
Simvastatin induces apoptosis and disruption of the actin cytoskeleton in human dental pulp cells and periodontal ligament fibroblasts.
Topics: Actin Cytoskeleton; Adolescent; Adult; Apoptosis; Cell Culture Techniques; Cell Nucleus; Cell Shape; Cell Survival; Cells, Cultured; Coloring Agents; Dental Pulp; Dose-Response Relationship, Drug; Fibroblasts; Flow Cytometry; Fluorescent Dyes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Periodontal Ligament; Phalloidine; Simvastatin; Tetrazolium Salts; Thiazoles; Time Factors; Young Adult | 2013 |
CYP19A1, MIF and ABCA1 genes are targets of the RORα in monocyte and endothelial cells.
Topics: Aromatase; ATP Binding Cassette Transporter 1; Cell Line; Chromatin Immunoprecipitation; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Gene Expression; Human Umbilical Vein Endothelial Cells; Humans; Intramolecular Oxidoreductases; Ligands; Macrophage Migration-Inhibitory Factors; Monocytes; Nuclear Receptor Subfamily 1, Group F, Member 1; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Simvastatin; Sulfonamides; Thiazoles | 2017 |